Claim Missing Document
Check
Articles

Found 2 Documents
Search

Simple Risk Index Score and Hospitalization Mortality in Patients with ST-Elevation Myocardial Infarction Marfianti, Erlina; Anwar, Sjaiful; Bima Aryatama, Achmad
Green Medical Journal Vol 2 No 1 April (2020): Green Medical Journal
Publisher : Fakultas Kedokteran Universitas Muslim Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (214.595 KB) | DOI: 10.33096/gmj.v2i1.35

Abstract

Introduction: Hospitalization mortality in ST-elevation Myocardial Infarction (STEMI) patients areaffected by several factors, including initial identification of the risks at hospital admission. Riskscore tools as a predictor of STEMI complication and death event in STEMI patients is a simple riskindex score. The aim of this study was to determine the association between simple risk index scoreand hospitalization mortality in STEMI patients.Methods: We retrospectively enrolled 60 consecutive patients who were admitted to our hospitaldiagnosed with STEMI. The simple risk index score was calculated for each patient using equation:heart rate x [age/10]2/systolic blood pressure. The patients were assigned into 2 groups according tothis score, high score and low score group. Incidence of death during hospitalization in STEMIpatients was recorded.Results: The total subjects were 60 people. The subjects consisted of 30 patients with low score and30 subjects with high score. The incidence of death during hospitalization in the group of high simplerisk index score were 26 patients, and in the group of low simple risk index score were 13 patients.The association between the simple risk index score and the deaths during hospitalization in STEMIpatients based on statistical analysis was significant (p= 0.00) and value of risk relative (RR) is 2.167;95% CI: 1.368-3.433; (p=0.000).Conclusion: Simple risk index score is associated with hospitalization mortality in ST-elevationmyocardial Infarction (STEMI) patients.
Repeat Acute Coronary Syndrome Following Percutaneous Coronary Intervention: A Case Report Rezkinanda, Alief; Anwar, Sjaiful
Jurnal Sehat Indonesia (JUSINDO) Vol. 8 No. 1 (2026): Jurnal Sehat Indonesia (JUSINDO)
Publisher : CV. Publikasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Percutaneous coronary intervention (PCI) is the primary reperfusion strategy for ST-elevation myocardial infarction (STEMI). Despite high procedural success rates, patients remain at risk for recurrent acute coronary syndrome (ACS), particularly those with significant comorbidities. We report a case of recurrent ACS in a patient less than one year following successful primary PCI. A 50-year-old female presented to the emergency department with typical angina, shortness of breath, nausea, and diaphoresis. Her medical history was significant for hypertension, type 2 diabetes mellitus, and a STEMI treated with primary PCI five months prior. Despite reported adherence to dual antiplatelet therapy (DAPT), she presented with tachycardia (104 bpm) and hypotension (155/55 mmHg). Electrocardiography revealed sinus tachycardia with pathological Q waves in leads V1–V4, consistent with a prior anterior myocardial infarction. Laboratory evaluation demonstrated hyperglycemia (228 mg/dL) and elevated cardiac troponin (44.2 ng/mL). The patient was diagnosed with recurrent ACS superimposed on an old anterior myocardial infarction. She was stabilized with loading doses of aspirin and clopidogrel and admitted to the Intensive Cardiac Care Unit (ICCU) for guideline-directed medical therapy, including beta-blockers and high-intensity statins. She was discharged in stable condition after five days. This case illustrates that recurrent ACS can occur shortly after successful revascularization, specifically in patients with persistent cardiovascular risk factors such as uncontrolled hyperglycemia and hypertension. It highlights the critical importance of aggressive secondary prevention, strict glycemic control, and close follow-up to mitigate the risk of adverse cardiac events in the post-PCI period.